Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin
NCT04004390 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2020-03-10
Summary
Our study evaluates the efficacy of IGIV treatment in PPS on clinical (walking and pain) and isokinetic (muscle strength) criteria, on patients with PS at Montpellier's Hospital
Conditions
- Post-Poliomyélitis Syndrom
Sponsors & Collaborators
-
University Hospital, Montpellier
lead OTHER
Principal Investigators
-
MOIZIARD Vincent, intern · University Hospital, Montpellier
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-28
- Primary Completion
- 2019-12-01
- Completion
- 2019-12-30
Countries
- France
Study Locations
More Related Trials
-
Intravenous Immunoglobulin for Unverricht-Lundborg Disease.
NCT03351569 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunotherapy and Paraneoplastic Neurological Syndromes
NCT02343211 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive Factors of Long Term Outcome in MMN
NCT04015934 ·Status: COMPLETED
-
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
NCT05114941 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT04529291 ·Status: WITHDRAWN ·Phase: NA
-
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
NCT05104762 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Immunoglobulin Dosage and Administration Form in CIDP and MMN
NCT02111590 ·Status: COMPLETED
-
A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations
NCT02413580 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
NCT01867645 ·Status: TERMINATED ·Phase: PHASE1
-
Transcriptome Analysis of the Peripheral Blood in CIDP
NCT02404298 ·Status: UNKNOWN ·Phase: NA
-
IVIG vs SCIG in CIDP
NCT05584631 ·Status: RECRUITING ·Phase: PHASE1
-
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
NCT01824251 ·Status: COMPLETED ·Phase: PHASE3
-
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
NCT00268788 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
NCT02473952 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
NCT00306033 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg
NCT01349270 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
NCT04303962 ·Status: UNKNOWN
-
A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
NCT02398994 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome
NCT02176863 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Long-Term Study of IGIV, 10% in Alzheimer´s Disease
NCT01736579 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients
NCT05311904 ·Status: COMPLETED
-
IVIg for Demyelination in Diabetes Mellitus
NCT02372149 ·Status: UNKNOWN ·Phase: PHASE4
-
Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy
NCT00004407 ·Status: TERMINATED ·Phase: NA
-
Study of CIDP Patients During IVIG Treatment
NCT00305266 ·Status: COMPLETED
-
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
NCT00666263 ·Status: COMPLETED ·Phase: PHASE3